Global Bioreactors and Fermenters Market Research Report 2023-Competitive Analysis, Status and Outlook by Type, Downstream Industry, and Geography, Forecast to 2029

Global Bioreactors and Fermenters Market Research Report 2023-Competitive Analysis, Status and Outlook by Type, Downstream Industry, and Geography, Forecast to 2029

Bioreactors and Fermenters are the containers which provide biological, biochemical, and biomechanical requirements for the optimal growth of the fermenting microorganisms and biochemical reactions on the industrial scale for the synthesis of desired products. Efficient bioreactors are capable of maintaining the desired biological activity by controlling the temperature, pH, fluid velocity, shear stress, mass and heat transfer, O2, CO2, and nutrient supply, reaction rate, and cell growth.

Bioreactors and fermenters are two words for basically the same thing. Scientists who cultivate bacteria, yeast, or fungi often use the term fermenters. The term bioreactor often relates to the cultivation of mammalian cells but is also generically used.

Market Overview:

The latest research study on the global Bioreactors and Fermenters market finds that the global Bioreactors and Fermenters market reached a value of USD 2900.34 million in 2022. It’s expected that the market will achieve USD 5308.79 million by 2028, exhibiting a CAGR of 10.6% during the forecast period.

During the COVID-19 pandemic, various countries have introduced ban policies, resulting in obstacles to transportation and logistics. This has caused supply problems in the industrial chain. On the supply side, delays in the start-up of supplier factories, insufficient supply and stagnant logistics have resulted in brands unable to provide more updated products or even normal production. However, thanks to the fact that bioreactors and fermentation tanks can be used in medicine, their sales and demand have not decreased but increased. During the research period of COVID-19 in various academic institutions and medical institutions, bioreactors and fermentation tanks are relatively common equipment, which increases their demand.

After the COVID-19 pandemic, people will pay more attention to biomedical research, and bioreactors and fermentation tanks will also be needed. In the long run, the growth momentum of the industry will remain unchanged, and the continued growth trend will remain unchanged.

Political Factors

This includes issues related to government policies on taxes, tariffs, and trade restrictions. It also includes employment laws and trade union activities and participation. Political stability of the environment is also important, and the political environment of Bioreactors and Fermenters is favorable.

During the rapid development of the Bioreactors and Fermenters industries, various countries have issued relevant legal documents to restrict and protect the manufacturing industry. From a national perspective, the medium and long-term development plan of the bioreactor industry should rationally develop and utilize resources, promote scientific and technological progress and innovation of bioreactors, and promote the sustainable development of bioreactors. From the corporate perspective, a series of related strategies have been formulated, such as cost control strategies, pricing strategies, competition strategies, mergers and acquisitions and restructuring strategies, marketing strategies, human resources strategies, financial management strategies, and internationalization strategies to ensure the company’s long-term development.

Social Factors

The global population is still increasing at a certain rate, and per capita income is constantly increasing. People's attention to medicine and biology is also increasing. In recent years, the number of biopharmaceutical companies, academic research institutions and clinical research institutions has been increasing. Due to the increase in R&D institutions, the increase in the adoption of bioreactors and the attention to biology and medicine, it is estimated that the bioreactor market will have considerable growth in the future. Bioreactors are used to grow organisms under controlled conditions, such as animal cells, bacteria or yeast. They are also used in the industrial production of antibodies, vaccines and medicines. Based on these factors, the Bioreactors and Fermenters industry will continue to maintain a certain speed or even faster growth for a long time in the future.

Region Overview:

In 2022, the share of the Bioreactors and Fermenters market in North America stood at 40.38%.

Company Overview:

Danaher Corporation (Pall) is one of the major players operating in the Bioreactors and Fermenters market, holding a share of 21.5% in 2023.

Danaher Corporation (Pall)

Danaher Corporation is an American globally diversified conglomerate with its headquarters in Washington, D.C. The company designs, manufactures, and markets professional, medical, industrial, and commercial products and services. The company's 4 platforms are Life Sciences, Diagnostics, Water Quality, and Environmental & Applied Solutions. Danaher Corporation acquired the biopharmaceutical business of General Electric Life Sciences on February 25, 2019.

Sartorius AG

Sartorius is an international pharmaceutical and laboratory equipment supplier. The company consists of the two divisions 'Bioprocess Solutions' and 'Lab Products & Services'. Bioprocess Solutions includes the segments filtration, fluid management, fermentation and purification and focuses on the production processes of the biopharmaceutical industry. Lab Products & Services focuses on the production and servicing of laboratory instruments and consumables, including water purification, weighing, liquid handling, microbiology, filtration and purification, and centrifuges.

Segmentation Overview:

Among different product types, Multiple-use Bioreactors segment is anticipated to contribute the largest market share in 2028.

Application Overview:

By application, the Academic and Research Institutes segment occupied the biggest share from 2018 to 2022.

Key Companies in the global Bioreactors and Fermenters market covered in Chapter 3:

Infors HT
Danaher Corporation (Pall)
Pierre Guerin (DCI-Biolafitte)
PBS Biotech, Inc.
Applikon Biotechnology
Eppendorf AG
Bioengineering AG
Thermo Fisher
ZETA Holding GmbH
Solaris Biotechnology srl
Merck KGaA
Sartorius AG
Praj Hipurity Systems

In Chapter 4 and Chapter 14.2, on the basis of types, the Bioreactors and Fermenters market from 2018 to 2029 is primarily split into:

Single-use Bioreactors
Multiple-use Bioreactors

In Chapter 5 and Chapter 14.3, on the basis of Downstream Industry, the Bioreactors and Fermenters market from 2018 to 2029 covers:

Biopharmaceutical Companies
CROs
Academic and Research Institute
Others

Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2018-2029) of the following regions are covered in Chapter 8 to Chapter 14:

North America (United States, Canada)
Europe (Germany, UK, France, Italy, Spain, Russia, Netherlands, Turkey, Switzerland, Sweden)
Asia Pacific (China, Japan, South Korea, Australia, India, Indonesia, Philippines, Malaysia)
Latin America (Brazil, Mexico, Argentina)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa)